Cargando…

Editorial: Primary and acquired resistance in lung cancer

Detalles Bibliográficos
Autores principales:	Bruno, Rossella, Simbolo, Michele, Petrini, Iacopo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646579/ https://www.ncbi.nlm.nih.gov/pubmed/38023142 http://dx.doi.org/10.3389/fonc.2023.1310331

Ejemplares similares

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation
por: Bruno, Rossella, et al.
Publicado: (2021)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
por: Pu, Zhangya, et al.
Publicado: (2022)

Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy
por: Li, Ling, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2023)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Editorial: Chemo-Resistance in Gastrointestinal Cancers
por: Li, Xia, et al.
Publicado: (2022)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
por: de Leeuw, Renée, et al.
Publicado: (2020)

Editorial: Tumor microenvironment in primary brain cancers
por: Niechi, Ignacio, et al.
Publicado: (2023)

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
por: Cucchiara, Federico, et al.
Publicado: (2020)

Editorial: Impact of tumor microenvironment on lung cancer
por: Levantini, Elena
Publicado: (2023)

Editorial: Brain and leptomeningeal metastases in lung cancer
por: Vavalà, Tiziana, et al.
Publicado: (2023)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Editorial: Controversies in the Local Management of Lung Cancer
por: Varlotto, John M., et al.
Publicado: (2018)

Transcriptome Profiling of Acquired Gefitinib Resistant Lung Cancer Cells Reveals Dramatically Changed Transcription Programs and New Treatment Targets
por: Wei, Nan, et al.
Publicado: (2020)

Editorial: Hallmark of cancer: Resisting cell death
por: Zhu, Yichao, et al.
Publicado: (2022)

Editorial: Imaging in non-small cell lung cancer
por: Liu, Yiyan
Publicado: (2023)

Editorial: Local ablative therapies for the management of lung cancer
por: Wei, Zhigang, et al.
Publicado: (2023)

Editorial: Influence of potential diagnostic biomarkers in lung cancer
por: Takam Kamga, Paul
Publicado: (2023)

Editorial: Long non-coding RNAs in lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2022)

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports
por: Michaux, Lionel, et al.
Publicado: (2023)

Editorial: LncRNAs in Cancer Metastasis and Therapy Resistance
por: Ahmad, Aamir, et al.
Publicado: (2021)

Editorial: Epigenetic and metabolic regulation of primary and metastatic brain cancers
por: Gimple, Ryan C., et al.
Publicado: (2023)

Editorial: The tumor microenvironment and malignant properties in primary liver cancer
por: Qu, Chen
Publicado: (2023)

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
por: Li, Ling, et al.
Publicado: (2020)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
por: Al-Rajabi, Taiseer, et al.
Publicado: (2023)

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
por: Yang, Ruoning, et al.
Publicado: (2022)

Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing
por: Sun, Dantong, et al.
Publicado: (2020)

Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities
por: Ferrara, Miriam Grazia, et al.
Publicado: (2021)

Editorial: The molecular mechanisms of metastasis and therapeutic resistance in breast cancer
por: Liang, Yuanke, et al.
Publicado: (2023)

Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
por: Muniyan, Sakthivel, et al.
Publicado: (2022)

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
por: Bertoni, Francesco, et al.
Publicado: (2022)

Editorial: Out-of-field second primary cancer induction: Dosimetry and modelling
por: Sánchez-Nieto, Beatriz, et al.
Publicado: (2022)

An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
por: Wu, Shang-Gin, et al.
Publicado: (2020)

LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
por: Xu, Tianwei, et al.
Publicado: (2020)

Implications of KRAS mutations in acquired resistance to treatment in NSCLC
por: Del Re, Marzia, et al.
Publicado: (2017)

MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
por: Kitowska, Kamila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e2p9raar1kclpiv7hdctkd6lr8